home / stock / bio / bio news


BIO News and Press, Bio-Rad Laboratories Inc. Class A From 10/06/22

Stock Information

Company Name: Bio-Rad Laboratories Inc. Class A
Stock Symbol: BIO
Market: NYSE
Website: bio-rad.com

Menu

BIO BIO Quote BIO Short BIO News BIO Articles BIO Message Board
Get BIO Alerts

News, Short Squeeze, Breakout and More Instantly...

BIO - Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO

Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO SYDNEY, AU, Oct 7, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CROs as a finalist in the Scrip Award for Best Full-Service CRO. This ...

BIO - Eisai Completes Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan

Eisai Completes Construction of Its New Injection/Research Building at Kawashima Industrial Park in Japan TOKYO, Oct 4, 2022 - (JCN Newswire) - Eisai Co., Ltd. announced that, as part of the strategic investment towards the realization of its medium-term business plan "EWAY Fu...

BIO - Bio Farma secures multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2)

Bio Farma secures multi-year Purchase Contract from UNICEF for its novel Oral Polio Vaccine type 2 (nOPV2) BANDUNG, INDONESIA, Oct 2, 2022 - (ACN Newswire) - PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export its novel Or...

BIO - Q&M Group awards 7 dentists with Performance Shares,12-year Service Agreements, and a Private Placement

Q&M Group awards 7 dentists with Performance Shares,12-year Service Agreements, and a Private Placement SINGAPORE, Sept 30, 2022 - (ACN Newswire) - Mainboard-listed Q&M Dental Group (Singapore) Limited [SGX: QC7] announced on 29 September 2022 the award of 2,014,245 sh...

BIO - Avance Clinical Wins International Health Award for Biotech CRO Services

Avance Clinical Wins International Health Award for Biotech CRO Services SYDNEY, AU, Sept 28, 2022 - (ACN Newswire) - Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier's Export Awards - International Health catego...

BIO - Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint

Eisai's Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint TOKYO, Sept 28, 2022 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced positive topline results from Eisai's large global Phase 3 confirmatory Clarity AD clinical trial of le...

BIO - Olympus Launches THUNDERBEAT Energy Device for Open Surgery

Olympus Launches THUNDERBEAT Energy Device for Open Surgery TOKYO and CENTER VALLEY, PA., Sept 28, 2022 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the rele...

BIO - Eisai: Metoject Subcutaneous Injection Syringe (Methotrexate) Approved in Japan for Rheumatoid Arthritis

Eisai: Metoject Subcutaneous Injection Syringe (Methotrexate) Approved in Japan for Rheumatoid Arthritis TOKYO, Sept 26, 2022 - (JCN Newswire) - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced today th...

BIO - Bio-Rad Laboratories hits 52-week low; down 40% YTD

Bio-Rad Laboratories ( NYSE: BIO ) on Monday hit a 52-week low of $436.90. Year to date, the stock is down ~40% . Over the last year, it is down ~43% . The life science research and clinical diagnostic products company was recently named a top pick in th...

BIO - Waters Corporation: Thesis Unchanged

Waters Corporation has continued to grow its top line, but some bottom line results have been weak. Fortunately, the picture for the year as a whole continues to look up and the firm's long-term outlook will probably be positive. But shares do not make for an attractive purchase a...

Previous 10 Next 10